Literature DB >> 29397583

Post-stroke hypertension control and receipt of health care services among veterans.

Dhanashri D Kohok1, Jason J Sico2,3,4, Fitsum Baye5,6, Laura Myers6,7, Jessica Coffing6,7, Masoor Kamalesh8,9, Dawn M Bravata6,7,8,9,10.   

Abstract

Many ischemic stroke patients do not achieve goal blood pressure (BP < 140/90 mm Hg). To identify barriers to post-stroke hypertension management, we examined healthcare utilization and BP control in the year after index ischemic stroke admission. This retrospective cohort study included patients admitted for acute ischemic stroke to a VA hospital in fiscal year 2011 and who were discharged with a BP ≥ 140/90 mm Hg. One-year post-discharge, BP trajectories, utilization of primary care, specialty and ancillary services were studied. Among 265 patients, 246 (92.8%) were seen by primary care (PC) during the 1-year post-discharge; a median time to the first PC visit was 32 days (interquartile range: 53). Among N = 245 patients with post-discharge BP data, 103 (42.0%) achieved a mean BP < 140/90 mm Hg in the year post-discharge. Provider follow-ups were: neurology (51.7%), cardiology (14.0%), nephrology (7.2%), endocrinology (3.8%), and geriatrics (2.6%) and ancillary services (BP monitor [30.6%], pharmacy [20.0%], nutrition [8.3%], and telehealth [8%]). Non-adherence to medications was documented in 21.9% of patients and was observed more commonly among patients with uncontrolled compared with controlled BP (28.7% vs 15.5%; P = .02). The recurrent stroke rate did not differ among patients with uncontrolled (4.2%) compared with controlled BP (3.8%; P = .89). Few patients achieved goal BP in the year post-stroke. Visits to primary care were not timely. Underuse of specialty as well as ancillary services and provider perception of medication non-adherence were common. Future intervention studies seeking to improve post-stroke hypertension management should address these observed gaps in care. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  hypertension-general; outcomes of care; stroke; stroke prevention

Mesh:

Substances:

Year:  2018        PMID: 29397583      PMCID: PMC8031130          DOI: 10.1111/jch.13194

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  20 in total

Review 1.  Update on the management of hypertension for secondary stroke prevention.

Authors:  Luis Castilla-Guerra; María Del Carmen Fernández-Moreno
Journal:  Eur Neurol       Date:  2012-05-23       Impact factor: 1.710

Review 2.  Multidisciplinary approaches to the management of high blood pressure.

Authors:  Sherilyn K D Houle; Trish Chatterley; Ross T Tsuyuki
Journal:  Curr Opin Cardiol       Date:  2014-07       Impact factor: 2.161

3.  Time to Reassess Blood-Pressure Goals.

Authors:  Aram V Chobanian
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

4.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Walter N Kernan; Bruce Ovbiagele; Henry R Black; Dawn M Bravata; Marc I Chimowitz; Michael D Ezekowitz; Margaret C Fang; Marc Fisher; Karen L Furie; Donald V Heck; S Claiborne Clay Johnston; Scott E Kasner; Steven J Kittner; Pamela H Mitchell; Michael W Rich; DeJuran Richardson; Lee H Schwamm; John A Wilson
Journal:  Stroke       Date:  2014-05-01       Impact factor: 7.914

5.  Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure.

Authors:  Christianne L Roumie; Alan J Zillich; Dawn M Bravata; Heather A Jaynes; Laura J Myers; Joseph Yoder; Eric M Cheng
Journal:  Stroke       Date:  2014-12-30       Impact factor: 7.914

6.  Recurrence after ischemic stroke in chinese patients: impact of uncontrolled modifiable risk factors.

Authors:  Gelin Xu; Xinfeng Liu; Wentao Wu; Renliang Zhang; Qin Yin
Journal:  Cerebrovasc Dis       Date:  2006-11-15       Impact factor: 2.762

7.  Secondary prevention for stroke in the United Kingdom: results from the National Sentinel Audit of Stroke.

Authors:  Anthony G Rudd; Derek Lowe; Alexandra Hoffman; Penny Irwin; M Pearson
Journal:  Age Ageing       Date:  2004-05       Impact factor: 10.668

8.  Risk factor modification in stroke prevention: the experience of a stroke clinic.

Authors:  L N Joseph; V L Babikian; N C Allen; M R Winter
Journal:  Stroke       Date:  1999-01       Impact factor: 7.914

9.  The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors.

Authors:  Joachim Schrader; Stephan Lüders; Anke Kulschewski; Jürgen Berger; Walter Zidek; Johannes Treib; Karl Einhäupl; Hans Christoph Diener; Peter Dominiak
Journal:  Stroke       Date:  2003-06-19       Impact factor: 7.914

Review 10.  PROGRESS: Prevention of Recurrent Stroke.

Authors:  Hisatomi Arima; John Chalmers
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-09-02       Impact factor: 3.738

View more
  2 in total

1.  Prevalence, treatment, and attributed mortality of elevated blood pressure among a nationwide population-based cohort of stroke survivors in China.

Authors:  Bin Wang; Xueke Bai; Yang Yang; Jianlan Cui; Lijuan Song; Jiamin Liu; Jiapeng Lu; Jun Cai
Journal:  Front Cardiovasc Med       Date:  2022-09-30

2.  Post-stroke hypertension control and receipt of health care services among veterans.

Authors:  Dhanashri D Kohok; Jason J Sico; Fitsum Baye; Laura Myers; Jessica Coffing; Masoor Kamalesh; Dawn M Bravata
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-04       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.